Home > Income Statement > VENUS REMEDIES

VENUS REMEDIES
Consolidated Net Profit

    Back to Income Statement
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹45 Cr₹28 Cr₹27 Cr₹41 Cr₹62 Cr

What is the latest Consolidated Net Profit of VENUS REMEDIES ?

The latest Consolidated Net Profit ratio of VENUS REMEDIES is ₹45 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹45 Cr
Mar2024₹28 Cr
Mar2023₹27 Cr
Mar2022₹41 Cr
Mar2021₹62 Cr

How is Consolidated Net Profit of VENUS REMEDIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹45 Cr
59.05
Mar2024 ₹28 Cr
7.25
Mar2023 ₹27 Cr
-34.77
Mar2022 ₹41 Cr
-34.07
Mar2021 ₹62 Cr -

Compare Consolidated Net Profit of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,058.5 Cr 3.6% 9.5% 134% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

3.6%

9.5%

134%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses